{"id":"008a486e-3b13-4424-9cba-f5d8816623a6","kind":"institutions","code":"UB-I3370","name":"Parker Institute for Cancer Immunotherapy","nameBasis":"original-brand","summary":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","description":"Parker Institute for Cancer Immunotherapy is an early-stage venture capital firm headquartered in the United States, focused on seed-, startup- and growth-stage startups.","country":"United States","category":null,"originalName":"Parker Institute for Cancer Immunotherapy","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:19.156Z","englishUpdatedAt":"2026-10-20T18:26:43.288Z","reviewedAt":"2026-10-20T18:26:43.288Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"126a2157a95758812ae9e6083855a77afca17558ada7c081d99603b38b308790","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"总部位于美国的Parker Institute for Cancer Immunotherapy，是一家早期风险投资机构，专注种子期、初创期到成长期创业公司。","sources":[],"related":[{"id":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","kind":"news","code":"1a46db22-7667-456e-8c7b-4c7e0228ab2c","name":"Xaira Therapeutics raises USD 1 billion in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Xaira Therapeutics完成10亿美元A轮融资","eventDate":"2024-04-23T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T10:58:16.219Z","englishUpdatedAt":"2026-10-15T17:19:59.284Z","reviewedAt":"2026-10-15T17:19:59.284Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5ad6b89d7cc3ff8e0f34199c32254c85f0812ae0842e0babbfa8689a3bf0349b","companyId":"93344362-1baf-4128-afab-79991be71cdc","foundedYear":null,"logoUrl":null,"path":"/news/1a46db22-7667-456e-8c7b-4c7e0228ab2c"}],"path":"/institutions/parker-institute-for-cancer-immunotherapy","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Parker Institute for Cancer Immunotherapy is a venture capital investor based in the United States with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/parker-institute-for-cancer-immunotherapy"}